Adamas Pharmaceuticals In... (ADMS)
NASDAQ: ADMS
· Real-Time Price · USD
8.22
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Adamas Pharmaceuticals Revenue
Adamas Pharmaceuticals reported an annual revenue of $74.46M, reflecting a undefined% growth. For the quarter ending September 30, 2021, Adamas Pharmaceuticals generated $25.9M in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2020 | 74.46M | +36.28% |
| Dec 31, 2019 | 54.64M | +60.48% |
| Dec 31, 2018 | 34.05M | +5862.52% |
| Dec 31, 2017 | 571K | -0.17% |
| Dec 31, 2016 | 572K | -70.15% |
| Dec 31, 2015 | 1.92M | -96.57% |
| Dec 31, 2014 | 55.85M | -21.45% |
| Dec 31, 2013 | 71.09M | +89.73% |
| Dec 31, 2012 | 37.47M | n/a |